Hamilton Lane Incorporated reports developments tied to its private markets investment platform, which provides investment solutions for institutional and private wealth clients. Company news commonly covers earnings releases, private credit and private infrastructure products, interval fund structures, capital-structure actions, and funds managed by Hamilton Lane participating in private equity, renewable infrastructure, and continuation-vehicle transactions.
Updates also include senior promotions across investment and client functions and product-access initiatives such as daily NAV pricing, quarterly repurchase features, and tokenized access where offered through specific fund structures.
Hamilton Lane (HLNE) named Hartley Rogers Co-Chief Executive Officer alongside Juan Delgado-Moreira, while Erik Hirsch became Executive Co-Chairman. Rogers will remain Chairman of the Board, and Delgado-Moreira has served as Co-Chief Executive Officer since January 1, 2024.
In his new role, Hirsch will help lead initiatives intended to advance the firm's long-term growth. He remains a board member and will continue speaking on behalf of Hamilton Lane in the media and on earnings calls. Hirsch identified investing capital, creating partnerships and acquisitions as areas of focus amid technological changes and an expanding client base.
Hamilton Lane (HLNE) is scheduled to release second-quarter fiscal 2027 results before the market opens on November 3, 2026. The quarter ended September 30, 2026. The earnings release and detailed presentation will be available on its shareholder website.
A webcast to discuss the results will begin at 11:00 a.m. ET that day. A replay will be available approximately two hours after the live broadcast and remain accessible for one year.
Hamilton Lane (HLNE) announced Executive Co-Chairman Mario Giannini will retire effective March 31, 2027, after more than three decades at the firm.
Giannini joined in 1993 and served as CEO from 2001 through 2023, when he became Executive Co-Chairman. Juan Delgado-Moreira and Erik Hirsch succeeded him as co-CEOs. Giannini will author Hamilton Lane's 2027 Market Overview before retiring. After his retirement, Hartley Rogers, currently the other Executive Co-Chairman, will continue as Executive Chairman and Chairman of the Board.
Hamilton Lane (HLNE) funds managed by the firm have completed a $105 million structured investment in Ontario fibre internet provider telMAX, alongside a parallel $110 million upsize of telMAX's existing credit facility from Power Sustainable Infrastructure Credit, Palistar Capital and MidStar Capital.
The combined $215 million growth financing is described as one of the largest rounds secured by an independent Canadian digital infrastructure business and is expected to accelerate telMAX's expansion of its 100% fibre network across Ontario. telMAX has already extended service to Markham, Barrie and Oakville and continues building across the Greater Toronto Area, including Brooklin, Stouffville, Newmarket, Aurora and Richmond Hill. With the new capital, telMAX plans to enter Burlington, Brampton and Mississauga, bringing high-speed fibre connectivity to hundreds of thousands of additional homes and businesses.
Columbia Threadneedle Investments (AMP) and Hamilton Lane (HLNE) announced a strategic collaboration to deliver investment solutions to the wealth channel, combining Columbia Threadneedle’s public markets and multi-asset capabilities with Hamilton Lane’s private markets platform and data analytics.
As part of this collaboration, Columbia Threadneedle filed a preliminary registration statement with the U.S. Securities and Exchange Commission for the Columbia Hamilton Lane Growth Innovation Fund/b, a public-private growth equity interval fund to be managed by Columbia Threadneedle. The fund’s launch is subject to SEC registration effectiveness and fund board approval and is expected to be offered to the wealth channel through financial advisors. Columbia Threadneedle reports it manages and advises of assets as of June 30, 2026, while Hamilton Lane reports $1.1 trillion in assets under management and supervision, including more than $146 billion in discretionary assets.
Cosette Pharmaceuticals, backed by funds managed by Hamilton Lane (HLNE), appointed Andrew Adams as Vice President, Supply Chain & Sourcing. Adams will oversee end-to-end supply chain functions, including supply planning, external manufacturing, inventory management, procurement, and new product launch readiness across Cosette’s portfolio.
Adams brings more than 15 years of pharmaceutical supply chain experience across branded, generic, biologic, and sterile products. He previously served as Vice President, Global Supply Chain and Sourcing at Par Health, where he led integration activities related to the Endo/Mallinckrodt merger, established global network governance and KPI reporting, and implemented integrated business planning that improved forecast accuracy, reduced inventory, and enhanced service levels.
Hamilton Lane (Nasdaq: HLNE) reported first-quarter fiscal 2027 results for the period ended June 30, 2026, and directed investors to a detailed presentation on its Shareholders website.
The company declared a quarterly dividend of $0.60 per Class A share, implying a target full-year dividend of $2.40, an 11% increase over the prior fiscal year. As of June 30, 2026, Hamilton Lane reported $1.1 trillion in assets under management and supervision, including $146.3 billion in discretionary and $914.1 billion in non-discretionary assets.
Hamilton Lane (Nasdaq: HLNE) served as the sole lead investor and only source of new outside capital in a single-asset continuation vehicle for Savant Capital Holdings, sponsored by Cynosure Partners. The continuation vehicle closed with approximately $270 million in total commitments, providing a liquidity option to Cynosure’s original limited partners roughly ten years after its initial Savant investment.
According to Hamilton Lane, Savant is a large independent fee-only RIA with over $57 billion in assets under management, serving more than 25,000 clients across 70 offices/b. Cynosure remains an active minority investor and Board member alongside Kelso, while Savant employees continue as the largest shareholder group.
Hamilton Lane (Nasdaq: HLNE) announced that its Board of Directors elected Michael Schmertzler as a new independent director, effective July 22, 2026. His appointment brings the Board to five independent directors, serving alongside three executive directors.
Schmertzler has extensive investment, corporate finance and governance experience, including academic roles at Yale University and leadership positions at multiple companies such as PTC Therapeutics, Berryville Holdings, Dispel, SHY Therapeutics and AgNovos. Earlier in his career, he held senior roles at Credit Suisse First Boston Equity Partners and Morgan Stanley.
Hamilton Lane (Nasdaq: HLNE) will release first quarter fiscal 2027 results for the period ended June 30, 2026, before the market opens on August 4, 2026. An earnings release and detailed presentation will be available on the company’s shareholder website.
Hamilton Lane will host a listen-only webcast conference call at 11:00 a.m. ET on August 4, with a replay accessible for one year on the same site.